CFG920
CFG920 is an orally active CYP17A1 inhibitor that suppresses androgen synthesis in the testes and adrenal glands. It is used in research for prostate cancer, investigating androgen signaling pathways in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
1260006-20-9
Field of Research
Metabolism Research
Smiles
O=C1N (CCN1C=2C=C (Cl) N=CC2) C=3C (C) =CC=NC3
Molecular Formula
C14H13ClN4O
Molecular Weight
288.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
